Skip to content
Screener

STERIS STE Other, net

Other, net at other companies

Baxter International logo
Baxter InternationalBAX
-$14M+41.7%
Stryker logo
StrykerSYK
-$147M-2,350%
Mesa Laboratories logo
Mesa LaboratoriesMLAB
-$214K
Boston Scientific logo
Boston ScientificBSX
$3M+130%
Fortive logo
FortiveFTV
-$2M-132%
Sotera Health logo
Sotera HealthSHC
-$1.26M-59.1%

Other financials

Income statement

See full
Revenue$1.5B+7.3%
Gross profit$684.1M+8.9%
Operating income$285.8M+16.2%
Net income$200.1M+12.8%
EPS (diluted)$2.04+14.0%

Balance sheet

See full
Cash & equivalents$482.3M+72.4%
Total debt$1.9B-0.5%
Total equity$7.2B+3.6%
Total assets$10.7B+3.2%

Cash flow

See full
Operating cash flow$367.1M-12.6%
CapEx$87.5M-6.5%
Free cash flow$279.6M-14.3%

Valuation

See full
Market cap$22.59B+3.8%
Enterprise value$24.04B+2.6%
P/E28.1×-5.6×
P/S3.7×-0.2×

Profitability

See full
Gross margin44.4%+0.3pp
Operating margin18.9%+2.3pp
Net margin13.3%+1.7pp
FCF margin15.3%-1.0pp

Returns & leverage

See full
Return on equity11.4%+1.7pp
Debt / equity0.3×0.0×
Current ratio1.9×-0.3×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The source filing: STERIS’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001628280-26-054830
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Acquisition related deferred or contingent consideration(0.1)(0.1)
Repurchases of ordinary shares(115.5)(10.6)
Cash dividends paid to ordinary shareholders(61.4)(56.2)
Stock option and other equity transactions, net1.39.3
Net cash used in financing activities(213.5)(213.1)
Effect of exchange rate changes on cash and cash equivalents(2.3)9.6
Increase in cash and cash equivalents42.8108.0
Cash and cash equivalents at beginning of period439.6171.7

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is STERIS's other, net?
STERIS (STE) reported other, net of $1.3M in Q2 2026.
How has STERIS's other, net changed year-over-year?
STERIS's other, net decreased by 86.0% year-over-year, from $9.3M to $1.3M.
What is the long-term trend for STERIS's other, net?
Over 3 years (2023 to 2026), STERIS's other, net has grown at a 162.1% compound annual growth rate (CAGR), from $1.83M to $32.9M.
What does other, net mean?
Includes miscellaneous cash flows related to financing activities that are not categorized as debt issuance, dividends, or share repurchases. This may include changes in non-controlling interests, debt issuance costs, or other unique financing-related transactions. It provides a comprehensive view of non-standard financing cash movements.

Ask your AI about STERIS's other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude